Search
Statistics
We have 222 registered usersThe newest registered user is raheelmemon
Our users have posted a total of 1140 messages in 613 subjects
If you are seeing this, you have attempted to link to the UpToDate widget but are experiencing a problem. Please visit UpToDate for more information.
Levodopa-Carbidopa Intestinal Gel (LCIG) Investigational Treatment For Advanced Parkinson's Disease
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psycho-Pharmacology
Page 1 of 1
Levodopa-Carbidopa Intestinal Gel (LCIG) Investigational Treatment For Advanced Parkinson's Disease
Abbott Reports Interim Results From Phase III Open-Label Study Of Investigational Treatment For Advanced Parkinson's Disease
Interim efficacy and safety results from a long-term, 54-week, Phase III open-label study of Abbott's investigational treatment for advanced Parkinson's disease showed that patients treated with levodopa-carbidopa intestinal gel (LCIG) for 12 weeks reported a decrease in "off" time and an increase in "on" time without troublesome dyskinesias. The results were reported at the International Congress of Parkinson's Disease and Movement Disorders in Toronto.
LCIG is administered via a surgically-implanted tube connected to a portable pump that delivers the medication directly to the small intestine, where it is then absorbed into the bloodstream, providing a continuous delivery of medication.
Check here for more details: Levodopa-Carbidopa Intestinal Gel (LCIG)
Interim efficacy and safety results from a long-term, 54-week, Phase III open-label study of Abbott's investigational treatment for advanced Parkinson's disease showed that patients treated with levodopa-carbidopa intestinal gel (LCIG) for 12 weeks reported a decrease in "off" time and an increase in "on" time without troublesome dyskinesias. The results were reported at the International Congress of Parkinson's Disease and Movement Disorders in Toronto.
LCIG is administered via a surgically-implanted tube connected to a portable pump that delivers the medication directly to the small intestine, where it is then absorbed into the bloodstream, providing a continuous delivery of medication.
Check here for more details: Levodopa-Carbidopa Intestinal Gel (LCIG)
Similar topics
» Exercise: a critical role in the treatment of Parkinson's disease
» New Investigational Medications for MDD
» Antidepressants use in Liver disease?
» Video Series: Alzheimer's Disease
» Psychotic Symptoms in Parkinson's Disease
» New Investigational Medications for MDD
» Antidepressants use in Liver disease?
» Video Series: Alzheimer's Disease
» Psychotic Symptoms in Parkinson's Disease
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psycho-Pharmacology
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
Sat Sep 10, 2016 1:45 pm by Admin
» L-Methylfolate: Who Will benefit
Sat Sep 03, 2016 3:00 pm by Admin
» Vitamins & Supplements in Clinical Practice.
Sun Aug 21, 2016 12:27 pm by Admin
» Imaging Biomarkers for Outcomes in Mild TBI
Fri Jul 22, 2016 12:37 pm by Admin
» Q.5 Clozapine Neutopenia
Mon Jul 11, 2016 8:43 pm by Admin
» Treating Disorders!
Mon Jul 04, 2016 1:52 am by troymackys
» Cortical Abnormalities in Adults & Adolescents with MDD
Sun Jul 03, 2016 12:59 pm by Admin
» Efficacy of Antipsychotics in Pediatric Acute Mania
Wed Jun 22, 2016 8:46 pm by Admin
» Obsessive Compulsive Disorder in Adults: Which Treatment is Better?
Tue Jun 21, 2016 9:34 pm by Admin